期刊文献+

一例合并t(9;22;16)(q34;q11;p13)的慢性髓细胞白血病 被引量:2

原文传递
导出
摘要 患者女,59岁,因发现血小板升高1个月于2010年5月14日入院。患者1月前曾因干咳去当地医院就诊,血常规检查提示白细胞9.3×10^9/L,
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2013年第2期247-248,共2页 Chinese Journal of Medical Genetics
  • 相关文献

参考文献9

  • 1Morris CM. Chronic myeloid leukemia: cytogenetic methods andapplications for diagnosis and treatment. Methods Mol Biol,2011,730:33-61.
  • 2Espinoza JP, Cdrdenas VJ,Jimenez EA, et al. A complextranslocation(9. 22; 16) (q34; qll. 2; pl3) in chronic myelocyticleukemia. Cancer Genet Cytogenet,2005,157: 175-177.
  • 3苏欣莹,曹琪,何凯莉,陈竺,陈赛娟.慢性粒细胞白血病染色体异常的研究[J].中华医学杂志,1999,79(1):34-37. 被引量:5
  • 4Zitzeisberger H, Bauchinger M, Wilmanns W, et al. Cytogeneticand molecular analysis of a “masked” Philadelphia chromosome inchronic and blastic phases of chronic myeioid leukemia. CancerGenet Cytogenet. 1590,47:219-225.
  • 5林茂芳,谢万灼,陈志妹,陈巧芳,黄河.236例慢性粒细胞白血病患者细胞遗传学特性观察[J].中华血液学杂志,2000,21(1):36-36. 被引量:14
  • 6Lauta VM, Chronic myelogenous leukemia: Elements ofconventional chemotherapy and an overview of autografting in thetreatment of the chronic phase. Med Oncol.2003.20 : 9 5-116.
  • 7Farag .Ruppert AS,Mrozek K.et al. Prognostic significance ofadditional cytogenetic abnormalities in newly diagnosed patientswith Philadelphia chromosome-positive chronic myelogenousleukemia treated with interferon alpha: a Cancer and LeukemiaGroup B study. Int J Oncol.2004,25: 143-151.
  • 8&:hoch C, Haferlach T. Kern W, et al. Occurrence of additionalchromosome aberrations in chronic myeloid leukemia patientstreated with imatinib mesylate. Leukemia.2003) 17:461-463.
  • 9Breccia M, Cannella L, Nanni M,. et al. Nilotinib can overridedasatinib resistance in chronic myeloid leukemia patients withsecondary resistance to imatinib first-line therapy. ActaHaematol,2007,118 :162-164.

二级参考文献2

  • 1Pandis N,Genes Chromosomes Cancer,1995年,12卷,173页
  • 2张之南,血液病诊断及疗效标准,1991年,193页

共引文献17

同被引文献20

  • 1Johansson B, Fioretos T, Mitelman F. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia[J]. Acta Haematol, 2002,107(2) :76-94.
  • 2Espinoza JP, Cardenas VJ, Jim6nez EA, et al. A complex translocation (9;22;16)(q34;q11. 2;p13) in chronic myelocytic leukemia[J]. Cancer Genet Cytogenet, 2005, 157(2):175-177.
  • 3J armuz M, Kroll R, Przybylowicz-Chalecka A, et al.Megakaryoeytic blast crisis in a chronic myeloid leukemia patient with a rare variant of Philadelphia rearrangement t(9;22;22) and a constitutional translocation t ( 3; 7 ) [J]. Cancer Genet Cytogenet, 2010, 199(1):45-47.
  • 4Schoch C, Haferlach T, Kern W, et al. Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate[J]. Leukemia, 2003, 17(2) : 461- 463.
  • 5Farag SS, Ruppert AS, Mr6zek K,et al. Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a cancer and leukemia groupBstudy[J]. Int J Oncol, 2004, 25(1) :143-151.
  • 6Ma Z, Morris SW, Valentine V,et al. Fusion of two novel genes, RBM15 and MKL1, in the t (1; 22) (p13; q13) of acute megakaryoblastic leukemia [J]. Nat Genet, 2001, 28 (3) : 220- 221.
  • 7程枫,沈云峰,庄芸,李晓雯.32例急性白血病免疫分型与预后关系的临床分析[J].中国药业,2009,18(1):55-57. 被引量:4
  • 8李江涛,常乃柏,范芸,顾惜春.慢性淋巴细胞白血病34例长期随访观察[J].中华内科杂志,2009,48(1):49-51. 被引量:2
  • 9李骏,柴铁,褚金龙,高彩凤,果丽实,李静.重组人血小板生成素在老年急性髓细胞白血病中的应用[J].中国肺癌杂志,2009,12(6):659-660. 被引量:3
  • 10叶玲琴.27例白血病输血小板致过敏反应的分析与护理[J].中国输血杂志,2010,23(1):54-55. 被引量:7

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部